PATENT CLAIM ANALYSIS

Application Number: 15961733
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["424", "433000"]

Abstract:
A contraceptive drug delivery system is provided in the form of a controlled release, bioerodible pellet for subdermal implantation. The pellet is bioerodible, and provides for the sustained release of a contraceptive agent over an extended time period. Bioerosion products are water soluble, bioresorbed, or both, obviating the need for surgical removal of the implant. Methods of using the drug delivery system, including in female contraception, are also provided.

Claim (Index 27):
The drug delivery system of  claim 1 , wherein the effective drug delivery time period is in the range of about one year to about three years.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 91.0
- Lexical Diversity: 1.6
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15720845', '15720921', '12234261', '13644929', '10592725']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7389603768005298
- 35 USC 102 Novelty (BERT): 0.5918683888559317
- Combined Prediction Score: 0.7242511780060701
- Mean Citation Score: 339.202132
- Max Citation Score: 618.0106
- Similarity Product: 397.0107992692589

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test